secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001193125-25-266938
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q3 revenue down 14% YoY to $30.3M; net loss widens to $9.8M
-------------------------------------------------------------------

- Revenue $30.3M (-14% YoY); LAL volume up 6% but LDD placements down 68%.
- Net loss $(9.8)M ($(0.24)/share) vs $(6.3)M ($(0.16)/share) in Q3 2024.
- Adjusted net loss $(1.7)M ($(0.04)/share) vs adjusted net gain $0.2M prior year.
- Narrowed FY2025 revenue guidance to $125-130M (prior $120-130M); raised gross margin guidance to 76-77%.
- Cash and investments $227.5M, unchanged from June 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525266938/0001193125-25-266938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525266938/rxst-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-266938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer